Journal of Controlled Release 2017-07-04

Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases

David Rufino-Ramos, Patrícia R. Albuquerque, Vitor Carmona, Rita Perfeito, Rui Jorge Nobre, Luis Pereira de Almeida

Index: 10.1016/j.jconrel.2017.07.001

Full Text: HTML

Abstract

Extracellular vesicles (EVs) are cell-derived membrane vesicles virtually secreted by all cells, including brain cells. EVs are a major term that includes apoptotic bodies, microvesicles and exosomes. The release of EVs has been recognized as an important modulator in cross-talking between neurons, astrocytes, microglia and oligodendrocytes, not only in central nervous system (CNS) physiology but also in neurodegenerative and neuroinflammatory disease states as well as in brain tumors, such as glioma. EVs are able to cross the blood brain barrier (BBB), spread to body fluids and reach distant tissues. This prominent spreading ability has suggested that EVs can be exploited into several different clinical applications ranging from biomarkers to therapeutic carriers.

Latest Articles:

Gastroresistant oral peptide for fluorescence imaging of colonic inflammation

2017-07-19

[10.1016/j.jconrel.2017.07.024]

Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field

2017-07-13

[10.1016/j.jconrel.2017.07.020]

Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice

2017-07-11

[10.1016/j.jconrel.2017.07.017]

Drug-eluting embolic microspheres for local drug delivery – State of the art ☆

2017-07-11

[10.1016/j.jconrel.2017.07.016]

Amelioration of atherosclerotic inflammation and plaques via endothelial adrenoceptor-targeted eNOS gene delivery using redox-sensitive polymer bearing l-arginine

2017-07-11

[10.1016/j.jconrel.2017.07.019]

More Articles...